Free Trial
→ An AI run of epic proportions is only getting started (From Timothy Sykes) (Ad) Buy DHCNI Stock  Free DHCNI Stock Alerts

Diversified Healthcare Trust (DHCNI) Financials

Diversified Healthcare Trust logo
$16.07 -0.26 (-1.56%)
Closing price 06/18/2025 03:51 PM Eastern
Extended Trading
$16.07 0.00 (0.00%)
As of 06/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Diversified Healthcare Trust

Annual Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 159 124 141 148 287 -88 -139 175 -16 -294 -370
Consolidated Net Income / (Loss)		 159 124 141 152 292 -83 -134 180 -16 -294 -370
Net Income / (Loss) Continuing Operations		 156 125 145 152 292 -83 -134 180 -16 -294 -370
Total Pre-Tax Income 		157 125 142 152 292 -83 -133 181 -21 -273 -371
Total Operating Income		 291 314 307 275 227 55 -6.37 -31 -94 -103 -126
Total Gross Profit		 845 999 1,058 1,075 1,117 1,040 1,632 1,383 1,284 1,410 1,495
Total Revenue		 845 999 1,058 1,075 1,117 1,040 1,632 1,383 1,284 1,410 1,495
Operating Revenue		 845 999 1,058 1,075 1,117 1,040 1,632 1,383 1,284 1,410 1,495
Total Cost of Revenue		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Operating Expenses		 553 685 751 800 890 985 1,638 1,414 1,377 1,514 1,621
Selling, General & Admin Expense		 39 43 47 517 537 526 1,267 1,126 1,136 1,200 1,263
Depreciation Expense		 185 258 288 277 286 289 270 271 239 284 285
Impairment Charge		 -0.01 0.19 19 5.08 66 115 107 -0.17 0.00 18 71
Restructuring Charge		 4.61 6.85 2.09 0.40 0.19 13 0.81 18 2.61 11 2.51
Total Other Income / (Expense), net		 -135 -188 -162 -124 65 -138 -127 213 73 -169 -246
Interest Expense		 135 153 168 173 179 180 202 258 239 194 236
Interest & Investment Income		 0.43 3.15 2.54 3.04 3.57 2.79 52 -22 16 24 8.95
Other Income / (Expense), net		 - -38 4.06 46 241 40 23 492 296 1.21 -19
Income Tax Expense		 0.58 0.57 0.42 0.45 0.48 0.44 1.25 1.43 0.71 0.45 0.47
Other Gains / (Losses), net		 0.09 0.02 0.14 0.61 0.52 0.40 0.00 0.00 6.06 -20 1.60
Basic Earnings per Share		 $0.80 $0.53 $0.60 $0.62 $1.21 ($0.37) ($0.59) $0.73 ($0.07) ($1.23) ($1.55)
Weighted Average Basic Shares Outstanding		 198.87M 232.93M 237.35M 237.42M 237.51M 237.60M 237.74M 237.97M 238.31M 238.84M 239.54M
Diluted Earnings per Share		 $0.80 $0.53 $0.60 $0.62 $1.21 ($0.37) ($0.59) $0.73 ($0.07) ($1.23) ($1.55)
Weighted Average Diluted Shares Outstanding		 198.89M 232.96M 237.38M 237.45M 237.55M 237.60M 237.74M 237.97M 238.31M 238.84M 239.54M
Weighted Average Basic & Diluted Shares Outstanding		 198.87M 232.93M 237.35M 237.42M 237.73M 237.90M 238.27M 238.99M 239.68M 240.42M 241.27M
Cash Dividends to Common per Share		 $1.56 $1.56 $1.56 $1.56 $1.56 $0.84 $0.18 $0.04 $0.04 $0.04 $0.04

Quarterly Income Statements for Diversified Healthcare Trust

This table shows Diversified Healthcare Trust's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -81 -65 -53 -73 -66 -103 -86 -98 -99 -87 -8.99
Consolidated Net Income / (Loss)		 -81 -65 -53 -73 -66 -103 -86 -98 -99 -87 -8.99
Net Income / (Loss) Continuing Operations		 -81 -65 -53 -73 -66 -103 -86 -98 -99 -87 -8.99
Total Pre-Tax Income 		-84 -63 -52 -75 -65 -80 -88 -85 -99 -99 -10
Total Operating Income		 -33 -18 -17 -33 -21 -33 -27 -16 -42 -41 -36
Total Gross Profit		 323 337 346 346 357 362 371 371 374 380 387
Total Revenue		 323 337 346 346 357 362 371 371 374 380 387
Operating Revenue		 323 337 346 346 357 362 371 371 374 380 387
Total Cost of Revenue		 0.00 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Operating Expenses		 356 355 363 379 377 394 398 387 416 421 423
Selling, General & Admin Expense		 295 291 292 294 305 309 315 310 324 314 323
Depreciation Expense		 60 63 65 68 67 84 70 68 69 78 68
Impairment Charge		 0.00 - 5.93 11 1.16 - 12 6.55 23 29 38
Restructuring Charge		 0.29 0.78 0.09 6.04 3.68 1.04 0.09 1.83 0.33 0.27 0.02
Other Special Charges / (Income)		 - - - - - - 0.00 - - - -7.52
Total Other Income / (Expense), net		 -51 -45 -35 -42 -45 -47 -61 -70 -57 -58 25
Interest Expense		 47 49 49 47 48 50 58 59 59 60 87
Interest & Investment Income		 1.43 22 12 5.13 3.24 2.96 2.24 2.40 2.58 1.74 2.10
Other Income / (Expense), net		 -5.04 -17 1.23 0.00 0.00 -0.03 -5.87 -13 0.11 0.04 110
Income Tax Expense		 0.01 -0.14 -0.03 0.22 0.19 0.07 0.19 0.17 0.15 -0.04 0.05
Other Gains / (Losses), net		 2.13 -2.63 -0.65 2.93 -0.15 -23 1.90 -12 0.53 11 1.49
Basic Earnings per Share		 ($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37) ($0.04)
Weighted Average Basic Shares Outstanding		 238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M 239.96M
Diluted Earnings per Share		 ($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37) ($0.04)
Weighted Average Diluted Shares Outstanding		 238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M 239.96M
Weighted Average Basic & Diluted Shares Outstanding		 239.70M 239.68M 239.68M 239.79M 240.45M 240.42M 240.39M 240.57M 241.28M 241.27M 241.25M
Cash Dividends to Common per Share		 - - - - - - - - $0.01 - $0.01

Annual Cash Flow Statements for Diversified Healthcare Trust

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -12 10 -8.23 12 23 -18 39 926 -329 -441 -97
Net Cash From Operating Activities		 351 406 424 419 393 266 159 -63 -40 10 112
Net Cash From Continuing Operating Activities		 351 406 424 419 393 266 159 -63 -40 10 112
Net Income / (Loss) Continuing Operations		 159 124 141 152 292 -83 -134 180 -16 -294 -370
Consolidated Net Income / (Loss)		 159 124 141 152 292 -83 -134 180 -16 -294 -370
Depreciation Expense		 185 258 288 277 286 289 270 271 239 284 285
Amortization Expense		 4.00 1.88 0.79 -0.07 0.43 -0.76 0.62 6.20 8.90 12 104
Non-Cash Adjustments To Reconcile Net Income		 -11 21 -6.37 -52 -189 111 35 -455 -274 36 87
Changes in Operating Assets and Liabilities, net		 14 1.04 0.94 42 3.10 -51 -13 -65 1.64 -28 6.82
Net Cash From Investing Activities		 -1,264 -1,213 -293 -221 99 86 -40 243 388 -202 -187
Net Cash From Continuing Investing Activities		 -1,264 -1,213 -293 -221 99 86 -40 243 388 -202 -187
Purchase of Property, Plant & Equipment		 -1,291 -1,205 -327 -277 -104 -222 -186 -228 -299 -235 -202
Acquisitions		 -0.83 - - - -129 -51 -2.53 0.00 -75 0.00 -21
Sale of Property, Plant & Equipment		 27 2.78 34 55 332 254 147 103 0.82 18 34
Divestitures		 - - - - 0.00 0.00 0.29 0.01 108 0.00 0.00
Sale and/or Maturity of Investments		 0.00 6.57 - 0.00 0.00 99 0.00 - 638 0.00 0.00
Other Investing Activities, net		 - - - 0.00 - 6.43 0.00 367 14 15 1.70
Net Cash From Financing Activities		 901 818 -140 -186 -469 -370 -79 747 -676 -250 -22
Net Cash From Continuing Financing Activities		 901 818 -140 -186 -469 -370 -79 747 -676 -250 -22
Repayment of Debt		 236 -1,326 -1,301 -821 -1,296 -1,143 -1,430 -514 -666 -990 -132
Repurchase of Common Equity		 0.00 -0.21 -0.45 -0.34 -0.41 -0.30 -0.17 -0.38 -0.17 -0.39 -0.90
Payment of Dividends		 -306 -356 -370 -384 -392 -221 -65 -32 -9.57 -9.60 -9.63
Issuance of Debt		 649 1,840 1,532 764 1,219 995 1,416 1,293 0.00 750 120

Quarterly Cash Flow Statements for Diversified Healthcare Trust

This table details how cash moves in and out of Diversified Healthcare Trust's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 -68 -113 -306 -26 -78 -32 -39 62 -8.69 -112 157
Net Cash From Operating Activities		 -5.09 -3.41 6.04 26 -14 -7.21 29 44 21 18 -3.24
Net Cash From Continuing Operating Activities		 -5.09 -3.41 6.04 26 -14 -7.21 29 44 21 18 -3.24
Net Income / (Loss) Continuing Operations		 -81 -65 -53 -73 -66 -103 -86 -98 -99 -87 -8.99
Consolidated Net Income / (Loss)		 -81 -65 -53 -73 -66 -103 -86 -98 -99 -87 -8.99
Depreciation Expense		 60 63 65 68 67 84 70 68 69 78 68
Amortization Expense		 1.95 2.00 1.76 2.27 2.32 5.22 25 26 26 27 26
Non-Cash Adjustments To Reconcile Net Income		 4.12 6.09 -3.42 14 1.58 24 17 32 22 17 -87
Changes in Operating Assets and Liabilities, net		 9.92 -9.53 -4.44 14 -19 -18 3.16 17 2.93 -16 -1.58
Net Cash From Investing Activities		 -44 -96 -57 -34 -60 -51 -59 -37 -25 -66 291
Net Cash From Continuing Investing Activities		 -44 -96 -57 -34 -60 -51 -59 -37 -25 -66 291
Purchase of Property, Plant & Equipment		 -72 -110 -60 -48 -60 -67 -47 -41 -47 -67 -40
Acquisitions		 - - 0.00 - - - -15 - - -5.72 -5.80
Sale of Property, Plant & Equipment		 0.03 - 3.55 - - 15 3.34 3.98 21 6.32 318
Sale and/or Maturity of Investments		 - - - - - - 0.00 - - - 17
Other Investing Activities, net		 - 14 - - - 0.53 0.00 - 1.53 - 1.31
Net Cash From Financing Activities		 -19 -13 -255 -18 -3.48 26 -8.56 54 -4.63 -64 -131
Net Cash From Continuing Financing Activities		 -19 -13 -255 -18 -3.48 26 -8.56 54 -4.63 -64 -131
Repayment of Debt		 -16 -11 -253 -15 -0.73 -721 -6.08 -63 -1.44 -61 -269
Repurchase of Common Equity		 -0.16 -0.01 -0.01 -0.03 -0.35 -0.01 -0.08 -0.04 -0.78 -0.00 -0.01
Payment of Dividends		 -2.39 -2.40 -2.40 -2.40 -2.40 -2.40 -2.40 -2.40 -2.41 -2.41 -2.41
Issuance of Debt		 - - - - - 750 0.00 - - - 140

Annual Balance Sheets for Diversified Healthcare Trust

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 5,968 7,160 7,228 7,294 7,160 6,654 6,476 6,624 6,002 5,446 5,137
Total Current Assets		 28 89 147 210 70 52 91 1,017 667 253 145
Cash & Equivalents		 28 38 32 31 55 37 74 635 658 246 145
Plant, Property, & Equipment, net		 7,196 6,309 6,347 6,370 6,342 5,891 5,716 5,076 4,864 4,798 4,340
Plant, Property & Equipment, gross		 6,222 7,457 7,618 7,825 7,876 7,462 7,411 6,814 6,693 6,818 6,423
Accumulated Depreciation		 -973 1,148 1,271 1,454 1,534 1,571 1,695 1,738 1,828 2,021 2,083
Total Noncurrent Assets		 5,941 762 734 714 748 711 670 531 471 395 652
Long-Term Investments		 - - - - 142 1.57 74 247 161 130 151
Intangible Assets		 473 604 514 472 419 338 287 49 45 34 26
Other Noncurrent Operating Assets		 5,468 157 219 241 187 371 309 235 264 232 474
Total Liabilities & Shareholders' Equity		 5,968 7,160 7,228 7,294 7,160 6,654 6,476 6,624 6,002 5,446 5,137
Total Liabilities		 3,016 3,800 4,028 4,017 3,981 3,777 3,857 3,961 3,363 3,109 3,178
Total Current Liabilities		 12 15 22 596 139 16 28 800 0.00 0.03 0.00
Total Noncurrent Liabilities		 3,004 3,785 4,006 3,421 3,842 3,761 3,829 3,161 3,363 3,089 3,178
Long-Term Debt		 2,801 3,479 3,714 3,079 3,509 3,502 3,499 2,877 3,018 2,804 2,911
Other Noncurrent Operating Liabilities		 81 191 186 246 246 183 262 285 346 285 261
Other Noncurrent Nonoperating Liabilities		 - - - - - - - - 0.00 - 6.02
Commitments & Contingencies		 - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,952 3,360 3,199 3,277 3,180 2,877 2,619 2,662 2,639 2,337 1,959
Total Preferred & Common Equity		 2,952 3,360 3,199 3,105 3,023 2,737 2,496 2,662 2,639 2,337 1,959
Total Common Equity		 2,952 3,360 3,199 3,105 3,023 2,737 2,496 2,662 2,639 2,337 1,959
Common Stock		 3,827 4,534 4,536 4,612 4,614 4,615 4,616 4,618 4,619 4,621 4,623
Retained Earnings		 1,354 1,478 1,619 1,766 2,141 2,053 1,913 2,088 2,072 1,778 1,408
Accumulated Other Comprehensive Income / (Loss)		 3.33 -33 35 87 -0.27 - - - - 0.00 -0.02
Other Equity Adjustments		 -2,232 -2,619 -2,990 -3,360 -3,731 -3,931 -4,034 -4,043 -4,053 -4,062 -4,072

Quarterly Balance Sheets for Diversified Healthcare Trust

This table presents Diversified Healthcare Trust's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2022 Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 6/30/2022 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 6,146 6,072 5,667 5,585 5,530 5,348 5,333 5,285 4,996
Total Current Assets		 868 801 383 357 279 208 266 257 303
Cash & Equivalents		 705 691 380 338 278 207 266 257 303
Plant, Property, & Equipment, net		 4,734 4,812 4,845 4,804 4,801 4,709 4,655 4,562 4,255
Plant, Property & Equipment, gross		 6,472 6,597 6,724 6,712 6,767 6,771 6,762 6,673 6,367
Accumulated Depreciation		 1,738 1,785 1,879 1,908 1,966 2,062 2,107 2,111 2,112
Total Noncurrent Assets		 543 460 439 425 450 431 413 467 438
Long-Term Investments		 159 159 153 155 154 146 134 134 142
Intangible Assets		 37 48 42 39 37 32 30 28 24
Other Noncurrent Operating Assets		 347 252 244 230 260 253 250 305 272
Total Liabilities & Shareholders' Equity		 6,146 6,072 5,667 5,585 5,530 5,348 5,333 5,285 4,996
Total Liabilities		 3,356 3,366 3,083 3,076 3,089 3,099 3,184 3,237 3,048
Total Current Liabilities		 700 700 450 450 450 0.22 0.00 0.00 0.00
Total Noncurrent Liabilities		 2,656 2,666 2,633 2,626 2,638 3,087 3,184 3,237 3,048
Long-Term Debt		 2,372 2,357 2,348 2,335 2,335 2,826 2,920 2,945 2,800
Other Noncurrent Operating Liabilities		 283 308 284 291 303 261 264 289 242
Other Noncurrent Nonoperating Liabilities		 - - - - - - 0.58 2.62 5.57
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 2,790 2,706 2,584 2,509 2,442 2,249 2,149 2,048 1,948
Total Preferred & Common Equity		 2,790 2,706 2,584 2,509 2,442 2,249 2,149 2,048 1,948
Total Common Equity		 2,790 2,706 2,584 2,509 2,442 2,249 2,149 2,048 1,948
Common Stock		 4,619 4,619 4,620 4,620 4,621 4,621 4,622 4,622 4,623
Retained Earnings		 2,219 2,137 2,019 1,947 1,881 1,692 1,594 1,495 1,399
Accumulated Other Comprehensive Income / (Loss)		 - - - - - -0.00 -0.03 0.01 0.00
Other Equity Adjustments		 -4,048 -4,050 -4,055 -4,057 -4,060 -4,065 -4,067 -4,069 -4,074

Annual Metrics And Ratios for Diversified Healthcare Trust

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.96% 18.21% 5.93% 1.58% 3.95% -6.89% 56.90% -15.25% -7.20% 9.87% 6.04%
EBITDA Growth		 12.32% 11.23% 12.17% -0.30% 26.21% -49.28% -24.95% 157.04% -71.86% -57.04% 25.91%
EBIT Growth		 10.16% -5.59% 13.13% 3.23% 45.72% -79.81% -82.52% 2,690.28% -56.11% -150.44% -41.82%
NOPAT Growth		 10.21% 7.50% -1.88% -10.40% 34.95% -83.06% -111.62% -593.08% -177.62% -10.09% -21.83%
Net Income Growth		 4.94% -21.85% 13.98% 7.44% 92.63% -128.34% -62.05% 233.97% -108.77% -1,761.11% -26.12%
EPS Growth		 4.94% -33.75% 13.21% 3.33% 190.32% -130.58% -59.46% 223.73% -109.59% -1,657.14% -26.02%
Operating Cash Flow Growth		 14.41% 15.57% 4.68% -1.22% -6.31% -32.33% -40.36% -139.94% 36.27% 125.98% 970.52%
Free Cash Flow Firm Growth		 -361.62% 200.07% -95.40% 3.50% 16.96% -8.08% 14.03% 142.27% -81.19% -111.21% 1,353.20%
Invested Capital Growth		 108.12% -47.37% 0.11% -0.51% -3.95% -4.39% -5.99% -15.76% -4.70% -1.09% -6.92%
Revenue Q/Q Growth		 3.61% 3.92% 0.64% 0.39% 0.61% -2.73% 8.57% -3.37% 0.01% 1.78% 1.22%
EBITDA Q/Q Growth		 4.06% -2.83% 1.96% 1.68% -18.73% 19.52% 1.10% 142.22% 244.82% 15.78% 2.96%
EBIT Q/Q Growth		 3.18% -11.93% 3.56% 5.19% -27.64% 226.02% 55.73% 1,358.19% 265.16% 2.73% -6.20%
NOPAT Q/Q Growth		 3.27% 0.20% 2.40% -9.88% -10.45% -64.61% 92.80% -239.61% 46.24% -16.22% -7.26%
Net Income Q/Q Growth		 -14.51% -22.38% 30.89% 18.26% -38.56% 44.54% 21.00% 189.18% -103.79% -14.53% 3.92%
EPS Q/Q Growth		 -14.51% -20.90% 33.33% 16.98% -38.89% 42.19% 20.27% 183.91% -104.02% -13.89% 3.73%
Operating Cash Flow Q/Q Growth		 3.19% 3.92% -0.61% 0.62% 5.98% -12.11% -30.81% -364.48% 53.66% -26.63% 29.26%
Free Cash Flow Firm Q/Q Growth		 -661.68% 775.38% -25.81% -11.31% 802.53% -33.44% -17.45% 390.05% -83.18% 62.67% 128.05%
Invested Capital Q/Q Growth		 125.24% -2.81% -1.26% -1.13% -9.36% -3.49% -1.54% -14.75% 1.47% -0.21% -3.31%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 200.00% 100.00% 100.00%
EBITDA Margin		 56.90% 53.54% 56.69% 55.65% 67.56% 36.80% 17.60% 53.39% 35.10% 13.73% 16.30%
Operating Margin		 34.49% 31.39% 29.03% 25.61% 64.07% 5.27% -0.39% -2.25% 10.46% -7.32% -8.41%
EBIT Margin		 34.49% 27.54% 29.41% 29.89% 83.80% 9.09% 1.01% 33.34% 33.53% -7.24% -9.68%
Profit (Net Income) Margin		 18.78% 12.41% 13.35% 14.12% 52.35% -7.97% -8.23% 13.01% -1.23% -20.82% -24.76%
Tax Burden Percent		 101.24% 98.80% 99.80% 100.10% 100.01% 100.04% 100.94% 99.21% 74.69% 107.67% 99.70%
Interest Burden Percent		 53.77% 45.61% 45.49% 47.21% 124.92% -87.64% -805.14% 39.33% -19.70% 267.10% 256.53%
Effective Tax Rate		 0.37% 0.46% 0.30% 0.30% 0.16% 0.00% 0.00% 0.79% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 6.01% 3.14% 4.46% 4.00% 10.56% 0.59% -0.07% -0.56% -1.33% -1.50% -1.91%
ROIC Less NNEP Spread (ROIC-NNEP)		 2.14% 0.37% -0.14% 0.61% 5.21% -2.85% -3.82% 6.69% 0.00% -11.03% -13.33%
Return on Net Nonoperating Assets (RNNOA)		 5.63% 0.79% -0.15% 0.69% 11.42% -3.32% -4.82% 7.37% 0.00% -10.30% -15.33%
Return on Equity (ROE)		 5.54% 3.93% 4.31% 4.69% 18.11% -2.74% -4.89% 6.81% 0.00% -11.80% -17.24%
Cash Return on Invested Capital (CROIC)		 -67.17% 65.21% 4.35% 4.51% 5.34% 5.07% 6.10% 16.55% 3.49% -0.40% 5.26%
Operating Return on Assets (OROA)		 10.96% 4.19% 4.33% 4.42% 6.48% 1.37% 0.25% 7.04% 3.21% -1.78% -2.74%
Return on Assets (ROA)		 5.91% 1.89% 1.96% 2.09% 8.09% -1.20% -2.05% 2.75% -0.25% -5.13% -7.00%
Return on Common Equity (ROCE)		 11.08% 3.93% 4.31% 4.56% 17.19% -2.60% -4.65% 6.65% 0.00% -11.80% -17.24%
Return on Equity Simple (ROE_SIMPLE)		 10.75% 3.69% 4.42% 4.89% 19.35% -3.03% -5.38% 6.76% -0.60% -12.56% -18.90%
Net Operating Profit after Tax (NOPAT)		 290 312 306 274 227 38 -4.46 -31 -66 -72 -88
NOPAT Margin		 34.36% 31.25% 28.94% 25.53% 20.28% 3.69% -0.27% -2.23% 7.32% -5.13% -5.89%
Net Nonoperating Expense Percent (NNEP)		 3.88% 2.77% 4.60% 3.39% 3.66% 3.44% 3.74% -7.25% -2.16% 9.53% 11.42%
Return On Investment Capital (ROIC_SIMPLE)		 4.94% 4.49% 4.36% 3.89% 3.28% 0.59% -0.07% -0.49% -1.16% -1.41% -1.86%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 4.61% 4.29% 4.40% 48.12% 48.11% 50.58% 77.63% 81.40% 88.46% 85.11% 84.46%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 65.51% 68.61% 70.97% 74.39% 159.38% 94.73% 100.39% 102.25% 214.62% 107.32% 108.41%
Earnings before Interest and Taxes (EBIT)		 291 275 311 321 468 95 17 461 202 -102 -145
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 481 535 600 598 755 383 287 738 451 194 244
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.87 0.65 0.94 1.06 0.73 0.63 0.36 0.26 0.06 0.38 0.28
Price to Tangible Book Value (P/TBV)		 1.04 0.80 1.12 1.25 0.85 0.72 0.41 0.26 0.06 0.38 0.29
Price to Revenue (P/Rev)		 3.04 2.20 2.85 3.07 1.99 1.67 0.55 0.49 0.23 0.63 0.37
Price to Earnings (P/E)		 16.19 17.74 21.36 22.36 7.73 0.00 0.00 3.91 0.00 0.00 0.00
Dividend Yield		 12.39% 0.00% 12.28% 11.23% 16.72% 11.52% 12.03% 1.40% 13.03% 1.09% 1.75%
Earnings Yield		 6.18% 5.64% 4.68% 4.47% 12.94% 0.00% 0.00% 25.56% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.42 0.83 0.97 1.03 0.88 0.84 0.73 0.61 0.48 0.69 0.68
Enterprise Value to Revenue (EV/Rev)		 6.47 5.71 6.32 6.54 5.28 5.19 2.71 2.24 1.83 2.35 2.03
Enterprise Value to EBITDA (EV/EBITDA)		 11.36 10.67 11.15 11.76 15.72 14.11 15.40 4.19 10.41 17.10 12.48
Enterprise Value to EBIT (EV/EBIT)		 18.75 20.74 21.50 21.89 12.60 57.12 267.72 6.71 11.59 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 18.82 18.28 21.85 25.64 26.03 140.68 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 15.57 14.07 15.76 16.77 15.01 20.31 27.91 0.00 0.00 315.72 27.09
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.88 22.39 22.74 16.30 16.24 11.67 3.37 27.16 0.00 12.53
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.99 1.07 1.19 1.15 1.17 1.24 1.36 1.38 0.00 1.20 1.42
Long-Term Debt to Equity		 1.98 1.07 1.19 0.97 1.13 1.24 1.36 1.08 0.00 1.20 1.42
Financial Leverage		 5.52 2.15 1.09 1.12 1.10 1.16 1.26 1.10 0.00 0.93 1.15
Leverage Ratio		 3.75 2.08 2.19 2.24 4.48 2.28 2.39 2.48 0.00 2.30 2.46
Compound Leverage Factor		 2.03 0.95 1.00 1.06 1.40 -2.00 -19.23 0.98 0.00 6.15 6.32
Debt to Total Capital		 49.75% 51.69% 54.42% 53.50% 108.02% 55.43% 57.66% 58.00% 53.35% 54.54% 58.70%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 8.46% 2.01% 0.00% 0.00% 12.62% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 99.51% 51.69% 54.42% 45.04% 104.00% 55.43% 57.66% 45.38% 53.35% 54.54% 58.70%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 2.44% 4.53% 2.18% 1.99% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 50.25% 48.31% 45.58% 44.06% 43.72% 42.39% 40.35% 42.00% 46.65% 45.46% 41.30%
Debt to EBITDA		 12.16 6.72 6.37 6.30 9.90 9.35 12.41 4.98 6.70 14.49 11.42
Net Debt to EBITDA		 6.02 6.56 6.12 5.95 9.34 9.21 11.84 3.27 9.76 12.54 10.21
Long-Term Debt to EBITDA		 12.16 6.72 6.37 5.31 9.53 9.35 12.41 3.90 13.40 14.49 11.42
Debt to NOPAT		 20.14 11.52 12.48 13.74 32.97 93.23 -799.87 -118.96 -26.85 -38.78 -31.61
Net Debt to NOPAT		 19.95 11.23 11.99 12.98 31.10 91.83 -762.96 -78.08 -19.66 -33.57 -28.25
Long-Term Debt to NOPAT		 20.14 11.52 12.48 11.57 31.74 93.23 -799.87 -93.08 -45.95 -38.78 -31.61
Altman Z-Score		 1.13 0.91 1.07 1.06 2.24 0.92 0.83 1.02 0.00 0.88 0.72
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 2.66% 5.10% 4.91% 4.80% 2.34% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.36 5.94 6.61 0.35 0.50 3.36 3.24 1.27 0.00 7,907.56 0.00
Quick Ratio		 4.73 5.94 6.61 0.33 0.79 2.40 2.65 0.79 0.00 7,875.63 0.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -6,486 6,491 299 309 362 332 379 919 173 -19 243
Operating Cash Flow to CapEx		 55.56% 33.73% 144.94% 189.36% 0.00% 0.00% 415.07% -50.92% -13.52% 4.84% 66.98%
Free Cash Flow to Firm to Interest Expense		 -48.00 42.49 1.78 1.79 2.02 1.85 1.88 3.56 2.36 -0.10 1.03
Operating Cash Flow to Interest Expense		 2.60 2.65 2.53 2.43 2.19 1.48 0.79 -0.25 -0.17 0.05 0.48
Operating Cash Flow Less CapEx to Interest Expense		 -6.75 -5.22 0.78 1.15 3.47 1.65 0.60 -0.73 -1.42 -1.06 -0.23
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.16 0.15 0.15 0.15 0.15 0.15 0.25 0.21 0.20 0.25 0.28
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 190.62 295.01
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.13 0.15 0.17 0.17 0.18 0.17 0.28 0.26 0.26 0.29 0.33
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.91 1.24
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.91 1.24
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 13,044 6,865 6,873 6,838 6,702 6,408 6,025 5,075 4,837 4,784 4,453
Invested Capital Turnover		 0.09 0.10 0.15 0.16 0.33 0.16 0.26 0.25 0.26 0.29 0.32
Increase / (Decrease) in Invested Capital		 6,776 -6,179 7.42 -35 -135 -294 -384 -949 -238 -53 -331
Enterprise Value (EV)		 5,463 5,705 6,691 7,034 5,897 5,400 4,424 3,096 2,346 3,310 3,041
Market Capitalization		 2,567 2,199 3,017 3,301 2,218 1,735 899 683 147 883 552
Book Value per Share		 $14.48 $14.15 $13.47 $13.07 $12.72 $11.50 $10.47 $11.14 $11.01 $9.72 $8.12
Tangible Book Value per Share		 $12.16 $11.60 $11.30 $11.08 $10.95 $10.08 $9.27 $10.94 $10.82 $9.58 $8.01
Total Capital		 5,876 6,954 7,020 7,048 6,915 6,455 6,186 6,339 5,656 5,141 4,743
Total Debt		 2,924 3,594 3,821 3,771 3,735 3,578 3,567 3,677 3,018 2,804 2,784
Total Long-Term Debt		 2,924 3,594 3,821 3,175 3,596 3,578 3,567 2,877 3,018 2,804 2,784
Net Debt		 2,896 3,505 3,673 3,560 3,523 3,525 3,402 2,413 2,198 2,427 2,488
Capital Expenditures (CapEx)		 1,263 1,202 293 221 -229 -32 38 124 299 217 168
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -12 -15 -22 0.00 0.00 -16 -28 0.00 8.72 6.05 4.06
Debt-free Net Working Capital (DFNWC)		 16 74 125 210 70 37 63 1,017 667 253 149
Net Working Capital (NWC)		 16 74 125 -386 -69 37 63 217 667 253 149
Net Nonoperating Expense (NNE)		 132 188 165 123 -66 121 130 -211 -50 221 282
Net Nonoperating Obligations (NNO)		 10,092 3,505 3,673 3,560 3,523 3,531 3,406 2,413 2,198 2,447 2,494
Total Depreciation and Amortization (D&A)		 189 260 289 277 287 288 271 277 248 296 389
Debt-free, Cash-free Net Working Capital to Revenue		 -1.38% -1.50% -2.11% 0.00% 0.00% -1.49% -1.72% 0.00% 1.36% 0.43% 0.27%
Debt-free Net Working Capital to Revenue		 3.77% 7.42% 11.82% 19.55% 12.54% 3.53% 3.85% 73.52% 105.57% 17.94% 9.94%
Net Working Capital to Revenue		 3.77% 7.42% 11.82% -35.91% -12.34% 3.53% 3.85% 15.68% 103.90% 17.94% 9.94%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.79 $0.53 $0.60 $0.62 $1.21 ($0.37) ($0.59) $0.73 ($0.07) ($1.23) ($1.55)
Adjusted Weighted Average Basic Shares Outstanding		 200.96M 232.93M 237.35M 237.42M 237.51M 237.60M 237.74M 237.97M 238.31M 238.84M 239.54M
Adjusted Diluted Earnings per Share		 $0.79 $0.53 $0.60 $0.62 $1.21 ($0.37) ($0.59) $0.73 ($0.07) ($1.23) ($1.55)
Adjusted Weighted Average Diluted Shares Outstanding		 200.98M 232.96M 237.38M 237.45M 237.55M 237.60M 237.74M 237.97M 238.31M 238.84M 239.54M
Adjusted Basic & Diluted Earnings per Share		 $0.79 $0.53 $0.60 $0.62 $1.21 ($0.37) ($0.59) $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 237.46M 237.47M 237.54M 237.63M 237.73M 237.90M 238.27M 238.99M 239.68M 240.42M 241.27M
Normalized Net Operating Profit after Tax (NOPAT)		 295 319 327 280 293 128 66 -14 -64 -52 -37
Normalized NOPAT Margin		 34.90% 31.95% 30.90% 26.04% 52.45% 12.32% 4.07% -0.99% -9.95% -3.68% -2.46%
Pre Tax Income Margin		 18.55% 12.56% 13.38% 14.11% 52.34% -7.96% -8.15% 13.11% -3.29% -19.33% -24.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 4.35 1.80 1.85 1.86 2.61 0.52 0.08 1.79 0.85 -0.53 -0.61
NOPAT to Interest Expense		 4.30 2.04 1.82 1.59 1.26 0.21 -0.02 -0.12 0.39 -0.37 -0.37
EBIT Less CapEx to Interest Expense		 -7.19 -6.07 0.11 0.58 7.77 0.70 -0.11 1.30 -0.40 -1.64 -1.33
NOPAT Less CapEx to Interest Expense		 -14.40 -5.83 0.08 0.31 6.53 0.39 -0.21 -0.60 -0.85 -1.49 -1.09
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 192.75% 287.49% 262.21% 253.24% 133.98% -267.02% -48.48% 17.72% -60.66% -3.27% -2.60%
Augmented Payout Ratio		 392.35% 287.66% 262.53% 253.46% 134.12% -267.38% -48.61% 17.94% -61.74% -3.40% -2.84%

Quarterly Metrics And Ratios for Diversified Healthcare Trust

This table displays calculated financial ratios and metrics derived from Diversified Healthcare Trust's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -4.30% 0.05% 11.36% 10.60% 10.41% 7.32% 7.15% 7.27% 4.80% 5.00% 4.34%
EBITDA Growth		 -48.28% 27.18% -85.64% -7.83% 100.40% 88.34% 22.15% 73.04% 8.95% 12.46% 170.57%
EBIT Growth		 -59.45% 24.32% -105.24% -66.80% 45.06% 8.08% -110.41% 12.57% -101.62% -25.90% 327.94%
NOPAT Growth		 -253.98% 72.83% 49.78% -72.79% 36.67% -79.29% -59.83% 52.58% -102.15% -26.12% -33.65%
Net Income Growth		 7.40% -117.81% -121.90% 33.65% 19.28% -57.01% -63.81% -34.85% -50.03% 14.74% 89.58%
EPS Growth		 10.53% -118.30% -121.78% 34.78% 17.65% -53.57% -63.64% -36.67% -46.43% 13.95% 88.89%
Operating Cash Flow Growth		 87.35% 93.21% 183.18% 204.43% -175.55% -111.72% 373.39% 72.47% 250.62% 352.39% -111.34%
Free Cash Flow Firm Growth		 609.33% -75.00% -110.65% -97.34% -100.38% -86.65% 169.11% 224.87% 3,773.50% 902.85% 319.15%
Invested Capital Growth		 -19.30% -4.70% 2.66% -1.12% -0.21% -1.09% -2.35% -2.33% -3.93% -6.92% -8.94%
Revenue Q/Q Growth		 3.16% 4.32% 2.71% 0.05% 2.98% 1.41% 2.56% 0.17% 0.61% 1.60% 1.91%
EBITDA Q/Q Growth		 -40.59% 1,467.78% 70.94% -26.28% 29.18% 15.69% 10.87% 4.43% -18.66% 19.42% 166.86%
EBIT Q/Q Growth		 -92.39% 919.07% 56.30% -112.98% 36.63% -55.84% -0.04% 11.51% -46.14% 2.69% 281.13%
NOPAT Q/Q Growth		 -72.91% 1,063.84% 7.90% -97.29% 36.63% -55.71% 17.90% 41.46% -170.13% 2.86% 13.00%
Net Income Q/Q Growth		 25.50% 19.84% 19.39% -37.82% 9.36% -55.92% 15.90% -13.45% -0.85% 11.39% 89.72%
EPS Q/Q Growth		 26.09% 17.65% 21.43% -36.36% 6.67% -53.57% 16.28% -13.89% 0.00% 9.76% 89.19%
Operating Cash Flow Q/Q Growth		 79.29% 33.13% 277.44% 325.04% -154.64% 48.62% 496.75% 54.86% -52.28% -13.91% -117.82%
Free Cash Flow Firm Q/Q Growth		 -3.21% -79.96% -160.86% 122.52% -113.99% 796.09% 215.14% 5.87% 58.17% 90.03% 31.72%
Invested Capital Q/Q Growth		 -0.65% 1.47% 0.19% -1.33% 0.25% -0.21% -1.07% -1.31% -1.39% -3.31% -3.22%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 100.00% 100.00% 200.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 7.51% 8.87% 29.51% 10.87% 13.64% 15.56% 16.82% 17.54% 14.18% 16.66% 43.64%
Operating Margin		 -10.24% -5.40% -9.32% -9.54% -5.87% -9.01% -7.22% -4.22% -11.32% -10.83% -9.24%
EBIT Margin		 -11.80% -10.53% -8.96% -9.54% -5.87% -9.02% -8.80% -7.78% -11.29% -10.82% 19.23%
Profit (Net Income) Margin		 -25.24% -19.39% -15.22% -20.96% -18.45% -28.37% -23.26% -26.35% -26.41% -23.04% -2.32%
Tax Burden Percent		 97.47% 0.00% 202.37% 96.40% 100.51% 128.37% 98.06% 114.61% 99.62% 88.36% 86.20%
Interest Burden Percent		 219.47% 177.05% 335.58% 227.92% 312.69% 244.96% 269.59% 295.69% 234.76% 240.99% -14.01%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -1.71% -0.98% -0.93% -1.88% -1.19% -1.85% -1.51% -0.91% -2.49% -2.45% -2.16%
ROIC Less NNEP Spread (ROIC-NNEP)		 -3.78% -3.26% -2.94% -4.17% -3.48% -5.28% -4.36% -4.54% -5.31% -4.83% -1.50%
Return on Net Nonoperating Assets (RNNOA)		 -4.17% -2.84% -2.19% -3.40% -3.01% -4.93% -4.28% -4.67% -5.80% -5.55% -1.73%
Return on Equity (ROE)		 -5.88% -3.81% -3.12% -5.27% -4.20% -6.78% -5.80% -5.58% -8.29% -8.01% -3.90%
Cash Return on Invested Capital (CROIC)		 19.10% 3.49% -3.07% -0.35% -1.08% -0.40% 0.72% 0.94% 2.26% 5.26% 7.27%
Operating Return on Assets (OROA)		 -2.30% -2.14% -0.95% -2.20% -1.40% -2.22% -2.29% -2.08% -3.09% -3.06% 5.62%
Return on Assets (ROA)		 -4.93% -3.94% -3.23% -4.83% -4.41% -6.99% -6.06% -7.05% -7.22% -6.51% -0.68%
Return on Common Equity (ROCE)		 -5.75% -3.81% -3.12% -5.27% -4.20% -6.78% -5.80% -5.58% -8.29% -8.01% -3.90%
Return on Equity Simple (ROE_SIMPLE)		 15.38% 0.00% -11.95% -10.84% -10.50% 0.00% -14.55% -16.40% -18.81% 0.00% -15.04%
Net Operating Profit after Tax (NOPAT)		 -23 -13 -12 -23 -15 -23 -19 -11 -30 -29 -25
NOPAT Margin		 -7.16% -3.78% -3.39% -6.68% -4.11% -6.31% -5.05% -2.95% -7.93% -7.58% -6.47%
Net Nonoperating Expense Percent (NNEP)		 2.07% 2.28% 2.01% 2.29% 2.30% 3.43% 2.85% 3.63% 2.81% 2.37% -0.66%
Return On Investment Capital (ROIC_SIMPLE)		 -0.40% -0.23% -0.22% -0.44% -0.28% -0.44% -0.37% -0.22% -0.59% -0.61% -0.53%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 91.44% 86.36% 168.74% 84.78% 85.66% 85.59% 85.00% 83.56% 86.62% 82.70% 83.58%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 110.24% 105.40% 209.68% 109.54% 105.87% 109.01% 107.22% 104.22% 111.32% 110.83% 109.24%
Earnings before Interest and Taxes (EBIT)		 -38 -35 -16 -33 -21 -33 -33 -29 -42 -41 74
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 24 30 51 38 49 56 62 65 53 63 169
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.08 0.06 0.24 0.21 0.19 0.38 0.26 0.34 0.49 0.28 0.30
Price to Tangible Book Value (P/TBV)		 0.08 0.06 0.25 0.21 0.19 0.38 0.26 0.34 0.50 0.29 0.30
Price to Revenue (P/Rev)		 0.17 0.23 0.24 0.39 0.33 0.63 0.41 0.50 0.68 0.37 0.38
Price to Earnings (P/E)		 0.54 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 4.29% 13.03% 6.15% 1.83% 2.11% 1.09% 1.65% 1.33% 0.96% 1.75% 1.67%
Earnings Yield		 186.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.48 0.48 1.06 0.58 0.59 0.69 0.65 0.70 0.77 0.68 0.68
Enterprise Value to Revenue (EV/Rev)		 1.81 1.83 1.95 2.07 2.03 2.35 2.13 2.22 2.41 2.03 1.94
Enterprise Value to EBITDA (EV/EBITDA)		 17.76 10.41 17.63 19.58 16.79 17.10 14.91 13.97 15.02 12.48 8.37
Enterprise Value to EBIT (EV/EBIT)		 0.00 11.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 120.42 196.43 315.72 92.43 62.84 40.95 27.09 36.48
Enterprise Value to Free Cash Flow (EV/FCFF)		 2.26 13.58 0.00 0.00 0.00 0.00 88.95 73.27 33.40 12.53 8.93
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 1.13 1.14 2.17 1.11 1.14 1.20 1.26 1.36 1.44 1.42 1.44
Long-Term Debt to Equity		 0.87 1.14 1.82 0.93 0.96 1.20 1.26 1.36 1.44 1.42 1.44
Financial Leverage		 1.10 0.87 1.49 0.82 0.86 0.93 0.98 1.03 1.09 1.15 1.15
Leverage Ratio		 2.57 2.38 4.54 2.21 2.25 2.30 2.28 2.34 2.41 2.46 2.46
Compound Leverage Factor		 5.64 4.22 15.23 5.05 7.05 5.64 6.14 6.93 5.65 5.94 -0.35
Debt to Total Capital		 53.06% 53.35% 103.99% 52.60% 53.29% 54.54% 55.68% 57.60% 58.98% 58.70% 58.98%
Short-Term Debt to Total Capital		 12.14% 0.00% 16.72% 8.50% 8.61% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 40.92% 53.35% 43.63% 44.10% 44.68% 54.54% 55.68% 57.60% 58.98% 58.70% 58.98%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 46.94% 46.65% 48.01% 47.40% 46.71% 45.46% 44.32% 42.40% 41.02% 41.30% 41.03%
Debt to EBITDA		 23.41 6.70 19.17 19.50 16.66 14.49 13.79 12.57 12.44 11.42 8.00
Net Debt to EBITDA		 16.06 4.88 15.49 15.91 14.07 12.54 12.06 10.85 10.79 10.21 6.73
Long-Term Debt to EBITDA		 18.05 6.70 16.08 16.35 13.97 14.49 13.79 12.57 12.44 11.42 8.00
Debt to NOPAT		 -25.04 -45.95 -45.91 -39.39 -44.76 -38.78 -35.63 -43.48 -35.86 -31.61 -29.67
Net Debt to NOPAT		 -17.18 -33.47 -37.11 -32.14 -37.81 -33.57 -31.16 -37.53 -31.11 -28.25 -24.96
Long-Term Debt to NOPAT		 -19.31 -45.95 -38.53 -33.02 -37.53 -38.78 -35.63 -43.48 -35.86 -31.61 -29.67
Altman Z-Score		 0.74 0.84 0.77 0.79 0.77 0.92 0.85 0.87 0.89 0.79 0.93
Noncontrolling Interest Sharing Ratio		 2.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.14 0.00 0.85 0.79 0.62 7,907.56 954.88 0.00 0.00 0.00 0.00
Quick Ratio		 0.99 0.00 1.69 0.75 0.62 7,875.63 950.11 0.00 0.00 0.00 0.00
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 1,126 226 -137 31 -4.33 30 95 100 159 302 398
Operating Cash Flow to CapEx		 -7.03% -3.09% 10.65% 53.90% -23.20% -13.92% 65.93% 119.64% 79.10% 30.12% 0.00%
Free Cash Flow to Firm to Interest Expense		 23.99 4.57 -2.81 0.65 -0.09 0.60 1.65 1.71 2.67 5.07 4.58
Operating Cash Flow to Interest Expense		 -0.11 -0.07 0.12 0.54 -0.29 -0.14 0.50 0.75 0.36 0.31 -0.04
Operating Cash Flow Less CapEx to Interest Expense		 -1.65 -2.30 -1.04 -0.46 -1.56 -1.17 -0.26 0.12 -0.09 -0.71 3.17
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.20 0.20 0.21 0.23 0.24 0.25 0.26 0.27 0.27 0.28 0.29
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 190.62 0.00 0.00 0.00 295.01 0.00
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.24 0.26 0.28 0.28 0.29 0.29 0.30 0.31 0.32 0.33 0.34
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 1.91 0.00 0.00 0.00 1.24 0.00
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 1.91 0.00 0.00 0.00 1.24 0.00
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 4,804 4,837 4,846 4,782 4,794 4,784 4,733 4,671 4,606 4,453 4,310
Invested Capital Turnover		 0.24 0.26 0.28 0.28 0.29 0.29 0.30 0.31 0.31 0.32 0.33
Increase / (Decrease) in Invested Capital		 -1,149 -238 126 -54 -10 -53 -114 -111 -189 -331 -423
Enterprise Value (EV)		 2,321 4,700 2,574 2,797 2,806 3,310 3,054 3,246 3,555 3,041 2,933
Market Capitalization		 223 147 630 525 454 883 583 725 1,000 552 576
Book Value per Share		 $11.32 $11.01 $10.78 $10.47 $10.18 $9.72 $9.40 $8.94 $8.51 $8.12 $8.07
Tangible Book Value per Share		 $11.11 $10.82 $10.60 $10.31 $10.03 $9.58 $9.27 $8.82 $8.40 $8.01 $7.97
Total Capital		 5,765 5,656 5,382 5,294 5,227 5,141 5,074 5,069 4,994 4,743 4,748
Total Debt		 3,059 3,018 2,798 2,785 2,785 2,804 2,826 2,920 2,945 2,784 2,800
Total Long-Term Debt		 2,359 3,018 2,348 2,335 2,335 2,804 2,826 2,920 2,945 2,784 2,800
Net Debt		 2,098 2,198 2,262 2,272 2,352 2,427 2,471 2,521 2,554 2,488 2,356
Capital Expenditures (CapEx)		 72 110 57 48 60 52 43 37 27 60 -279
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 8.72 0.00 -0.31 -0.43 6.05 -0.22 0.00 0.00 4.06 0.00
Debt-free Net Working Capital (DFNWC)		 801 667 383 357 279 253 208 266 257 149 303
Net Working Capital (NWC)		 101 667 -67 -93 -171 253 208 266 257 149 303
Net Nonoperating Expense (NNE)		 58 53 41 49 51 80 68 87 69 59 -16
Net Nonoperating Obligations (NNO)		 2,098 2,198 2,262 2,273 2,353 2,447 2,484 2,521 2,557 2,494 2,362
Total Depreciation and Amortization (D&A)		 62 65 67 71 70 89 95 94 95 104 94
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.68% 0.00% -0.02% -0.03% 0.43% -0.02% 0.00% 0.00% 0.27% 0.00%
Debt-free Net Working Capital to Revenue		 62.40% 51.95% 29.02% 26.39% 20.11% 17.94% 14.49% 18.19% 17.36% 9.94% 20.02%
Net Working Capital to Revenue		 7.85% 103.90% -5.11% -6.89% -12.36% 17.94% 14.49% 18.19% 17.36% 9.94% 20.02%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding		 238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M 239.96M
Adjusted Diluted Earnings per Share		 ($0.34) ($0.28) ($0.22) ($0.30) ($0.28) ($0.43) ($0.36) ($0.41) ($0.41) ($0.37) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding		 238.34M 238.31M 238.59M 238.68M 238.89M 238.84M 239.19M 239.33M 239.67M 239.54M 239.96M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 239.70M 239.68M 239.68M 239.79M 240.45M 240.42M 240.39M 240.57M 241.28M 241.27M 241.25M
Normalized Net Operating Profit after Tax (NOPAT)		 -23 -12 -7.51 -11 -11 -22 -10 -5.10 -13 -8.27 -3.35
Normalized NOPAT Margin		 -7.10% -3.62% -2.17% -3.17% -3.16% -6.11% -2.74% -1.37% -3.55% -2.18% -0.87%
Pre Tax Income Margin		 -25.89% -18.65% -30.08% -21.74% -18.36% -22.10% -23.73% -22.99% -26.51% -26.07% -2.69%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -0.81 -0.72 -0.63 -0.70 -0.44 -0.65 -0.57 -0.49 -0.71 -0.69 0.86
NOPAT to Interest Expense		 -0.49 -0.26 -0.46 -0.49 -0.31 -0.45 -0.33 -0.19 -0.50 -0.48 -0.29
EBIT Less CapEx to Interest Expense		 -2.36 -2.95 -1.80 -1.70 -1.70 -1.68 -1.32 -1.12 -1.16 -1.70 4.06
NOPAT Less CapEx to Interest Expense		 -2.04 -2.49 -1.62 -1.49 -1.57 -1.48 -1.08 -0.81 -0.95 -1.50 2.92
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 3.62% -60.66% -3.10% -3.52% -3.74% -3.27% -2.93% -2.73% -2.50% -2.60% -3.29%
Augmented Payout Ratio		 3.66% -61.74% -3.16% -3.60% -3.89% -3.40% -3.08% -2.86% -2.73% -2.84% -3.57%

Key Financial Trends

Diversified Healthcare Trust’s Q1 2025 results show continued revenue growth and improving cash generation, but profitability remains under pressure and leverage is high.

  • Free Cash Flow to Firm of $397.9 M in Q1 2025, up ~31% from $302.1 M in Q4 2024
  • Cash & Equivalents climbed to $302.6 M in Q1 2025 versus $207.1 M in Q1 2024, boosting liquidity
  • Revenue rose to $386.9 M in Q1 2025, +4.3% year-over-year from $370.8 M in Q1 2024
  • Proceeds from sale of PP&E totaled $318.2 M in Q1 2025, supporting investing cash flows
  • SG&A remained elevated at 83.6% of revenue in Q1 2025, in line with recent quarters
  • Non-cash charges (impairment, restructuring) continue to add ~ $40 M to operating expenses
  • Net loss of $9.0 M in Q1 2025, improved from a loss of $86.3 M in Q1 2024 but still negative
  • Operating margin stayed in the red at –9.2% in Q1 2025
  • Net debt/EBITDA remained high at ~ 6.7 x in Q1 2025 (versus ~ 12 x a year ago)
  • Interest expense surged to $86.9 M in Q1 2025, weighing on earnings
06/19/25 10:07 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Diversified Healthcare Trust's Financials

When does Diversified Healthcare Trust's fiscal year end?

According to the most recent income statement we have on file, Diversified Healthcare Trust's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Diversified Healthcare Trust's net income changed over the last 10 years?

Diversified Healthcare Trust's net income appears to be on a downward trend, with a most recent value of -$370.26 million in 2024, falling from $158.64 million in 2014. The previous period was -$293.57 million in 2023.

What is Diversified Healthcare Trust's operating income?
Diversified Healthcare Trust's total operating income in 2024 was -$125.83 million, based on the following breakdown:
  • Total Gross Profit: $1.50 billion
  • Total Operating Expenses: $1.62 billion
How has Diversified Healthcare Trust's revenue changed over the last 10 years?

Over the last 10 years, Diversified Healthcare Trust's total revenue changed from $844.89 million in 2014 to $1.50 billion in 2024, a change of 77.0%.

How much debt does Diversified Healthcare Trust have?

Diversified Healthcare Trust's total liabilities were at $3.18 billion at the end of 2024, a 2.2% increase from 2023, and a 5.4% increase since 2014.

How much cash does Diversified Healthcare Trust have?

In the past 10 years, Diversified Healthcare Trust's cash and equivalents has ranged from $27.59 million in 2014 to $658.07 million in 2022, and is currently $144.58 million as of their latest financial filing in 2024.

How has Diversified Healthcare Trust's book value per share changed over the last 10 years?

Over the last 10 years, Diversified Healthcare Trust's book value per share changed from 14.48 in 2014 to 8.12 in 2024, a change of -43.9%.


Related Companies

This page (NASDAQ:DHCNI) was last updated on 6/19/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Crypto Is Pumping Again – Now Comes the Real Opportunity
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
379 passengers walked away from this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored